Financial Architects (New Jersey)’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-160
| Closed | -$15K | – | 1073 |
|
|
2019
Q1 | $15K | Hold |
160
| – | – | ﹤0.01% | 866 |
|
|
2018
Q4 | $12K | Hold |
160
| – | – | ﹤0.01% | 843 |
|
|
2018
Q3 | $14K | Buy |
160
+50
| +45% | +$4.38K | ﹤0.01% | 872 |
|
|
2018
Q2 | $11K | Sell |
110
-30
| -21% | -$3K | ﹤0.01% | 955 |
|
|
2018
Q1 | $17K | Hold |
140
| – | – | ﹤0.01% | 799 |
|
|
2017
Q4 | $18K | Hold |
140
| – | – | ﹤0.01% | 859 |
|
|
2017
Q3 | $16K | Hold |
140
| – | – | ﹤0.01% | 914 |
|
|
2017
Q2 | $11K | Buy |
140
+60
| +75% | +$4.71K | ﹤0.01% | 993 |
|
|
2017
Q1 | $4K | Buy |
+80
| New | +$4K | ﹤0.01% | 1210 |
|